1 |
ACTELION PHARMACEUTICALS US, INC. et al v. ALEMBIC PHARMACEUTICALS LIMITED et al |
2:23-cv-01902 |
D.N.J. |
|
|
|
|
2 |
ACTELION PHARMACEUTICALS US, INC. et al v. ALEMBIC PHARMACEUTICALS LIMITED et al |
2:23-cv-01902 |
D.N.J. |
|
|
|
|
3 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al |
1:18-cv-01762 |
D.Del. |
|
|
|
|
4 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al |
1:18-cv-01762 |
D.Del. |
|
|
|
|
5 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al |
1:18-cv-01762 |
D.Del. |
|
|
|
|
6 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
7 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
8 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
9 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
10 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
11 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
12 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
13 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
14 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
15 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
16 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
17 |
Eli Lilly and Company et al v. Alembic Pharmaceuticals Ltd. et al |
1:16-cv-01120 |
E.D.Va. |
|
|
|
|
18 |
Eli Lilly and Company et al v. Alembic Pharmaceuticals Ltd. et al |
1:16-cv-01120 |
E.D.Va. |
|
|
|
|
19 |
AstraZeneca LP et al v. Alembic Pharmaceuticals LTD et al. |
1:15-cv-01003 |
D.Del. |
|
|
|
|
20 |
AstraZeneca LP et al v. Alembic Pharmaceuticals LTD et al. |
1:15-cv-01003 |
D.Del. |
|
|
|
|
21 |
AstraZeneca LP et al v. Alembic Pharmaceuticals LTD et al. |
1:15-cv-01003 |
D.Del. |
|
|
|
|
22 |
AstraZeneca LP et al v. Alembic Pharmaceuticals LTD et al. |
1:15-cv-01003 |
D.Del. |
|
|
|
|
23 |
Forest Laboratories LLC et al v. Alembic Pharmaceuticals Ltd. et al |
1:15-cv-00158 |
D.Del. |
|
|
|
|
24 |
Forest Laboratories LLC et al v. Alembic Pharmaceuticals Ltd. et al |
1:15-cv-00158 |
D.Del. |
|
|
|
|
25 |
Forest Laboratories LLC et al v. Sigmapharm Laboratories LLC et al |
1:14-cv-01119 |
D.Del. |
|
|
|
|
26 |
Forest Laboratories LLC et al v. Sigmapharm Laboratories LLC et al |
1:14-cv-01119 |
D.Del. |
|
|
|
|
27 |
OTSUKA PHARMACEUTICAL CO., LTD. v. ALEMBIC PHARMACEUTICALS LIMITED |
1:14-cv-02982 |
D.N.J. |
|
|
|
|